|Mr. Michael J. Farrell BE, SM, MBA||CEO & Director||2.28M||165.69k||1972|
|Mr. Robert A. Douglas||Pres & COO||1.75M||N/A||1960|
|Mr. Brett A. Sandercock||Chief Financial Officer||861.39k||N/A||1967|
|Mr. David B. Pendarvis||Chief Admin. Officer, Global Gen. Counsel & Sec.||1.02M||2.83M||1959|
|Mr. James Hollingshead||Pres of Sleep Bus.||1.17M||462.46k||1963|
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
ResMed Inc.’s ISS Governance QualityScore as of April 1, 2019 is 5. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 7.